Northern Trust: Inovio Pharmaceuticals INO Historial de posiciones en acciones
Comprado
Mantenidas
Vendido
| Trimestre | Valor de mercado | Estado | Acciones |
Cambio en la posición | Valor operado | Peso en el portafolio | Puesto en el portafolio | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | USD 287 k | Compra |
235,260
+60,866
| +35% | +USD 67.9 k | ﹤0.01% | 3800 |
|
|
2026
Q2 | USD 192 k | Venta |
174,394
-124,476
| -42% | -USD 148 k | ﹤0.01% | 3948 |
|
|
2026
Q1 | USD 520 k | Venta |
298,870
-1,114
| -0.4% | -USD 1.83 k | ﹤0.01% | 3607 |
|
|
2025
Q4 | USD 522 k | Compra |
299,984
+61,513
| +26% | +USD 135 k | ﹤0.01% | 3641 |
|
|
2025
Q3 | USD 558 k | Venta |
238,471
-15,954
| -6% | -USD 30.5 k | ﹤0.01% | 3614 |
|
|
2025
Q2 | USD 518 k | Venta |
254,425
-211,353
| -45% | -USD 405 k | ﹤0.01% | 3633 |
|
|
2025
Q1 | USD 759 k | Compra |
465,778
+246,721
| +113% | +USD 495 k | ﹤0.01% | 3395 |
|
|
2024
Q4 | USD 401 k | Compra |
219,057
+13,269
| +6% | +USD 58.7 k | ﹤0.01% | 3735 |
|
|
2024
Q3 | USD 1.19 M | Compra |
205,788
+144,676
| +237% | +USD 1.19 M | ﹤0.01% | 3279 |
|
|
2024
Q2 | USD 494 k | Compra |
61,112
+12,060
| +25% | +USD 127 k | ﹤0.01% | 3516 |
|
|
2024
Q1 | USD 681 k | Compra |
49,052
+2,744
| +6% | +USD 23.7 k | ﹤0.01% | 3461 |
|
|
2023
Q4 | USD 283 k | Compra |
46,308
+6,391
| +16% | +USD 31.5 k | ﹤0.01% | 3748 |
|
|
2023
Q3 | USD 186 k | Compra |
39,917
+1,104
| +3% | +USD 6.1 k | ﹤0.01% | 3839 |
|
|
2023
Q2 | USD 208 k | Venta |
38,813
-150,838
| -80% | -USD 1.22 M | ﹤0.01% | 3817 |
|
|
2023
Q1 | USD 1.87 M | Venta |
189,651
-5,854
| -3% | -USD 100 k | ﹤0.01% | 2971 |
|
|
2022
Q4 | USD 3.66 M | Compra |
195,505
+13,870
| +8% | +USD 314 k | ﹤0.01% | 2673 |
|
|
2022
Q3 | USD 3.76 M | Compra |
181,635
+15,619
| +9% | +USD 400 k | ﹤0.01% | 2659 |
|
|
2022
Q2 | USD 3.45 M | Compra |
166,016
+8,362
| +5% | +USD 236 k | ﹤0.01% | 2746 |
|
|
2022
Q1 | USD 6.79 M | Venta |
157,654
-6,173
| -4% | -USD 278 k | ﹤0.01% | 2390 |
|
|
2021
Q4 | USD 9.8 M | Venta |
163,827
-4,204
| -3% | -USD 337 k | ﹤0.01% | 2242 |
|
|
2021
Q3 | USD 14.4 M | Venta |
168,031
-4,360
| -3% | -USD 438 k | ﹤0.01% | 2022 |
|
|
2021
Q2 | USD 19.2 M | Venta |
172,391
-4,050
| -2% | -USD 389 k | ﹤0.01% | 1915 |
|
|
2021
Q1 | USD 19.6 M | Compra |
176,441
+17,800
| +11% | +USD 2.34 M | ﹤0.01% | 1837 |
|
|
2020
Q4 | USD 16.8 M | Venta |
158,641
-1,044
| -0.7% | -USD 139 k | ﹤0.01% | 1916 |
|
|
2020
Q3 | USD 22.2 M | Compra |
159,685
+2,901
| +2% | +USD 605 k | ﹤0.01% | 1548 |
|
|
2020
Q2 | USD 50.7 M | Compra |
156,784
+55,493
| +55% | +USD 8.91 M | 0.01% | 886 |
|
|
2020
Q1 | USD 9.04 M | Compra |
101,291
+14,058
| +16% | +USD 867 k | ﹤0.01% | 1935 |
|
|
2019
Q4 | USD 3.46 M | Venta |
87,233
-8,909
| -9% | -USD 268 k | ﹤0.01% | 2806 |
|
|
2019
Q3 | USD 2.36 M | Compra |
96,142
+9,621
| +11% | +USD 293 k | ﹤0.01% | 3008 |
|
|
2019
Q2 | USD 3.05 M | Venta |
86,521
-3,413
| -4% | -USD 136 k | ﹤0.01% | 2825 |
|
|
2019
Q1 | USD 4.02 M | Compra |
89,934
+2,558
| +3% | +USD 129 k | ﹤0.01% | 2680 |
|
|
2018
Q4 | USD 4.19 M | Compra |
87,376
+898
| +1% | +USD 54.6 k | ﹤0.01% | 2614 |
|
|
2018
Q3 | USD 5.77 M | Compra |
86,478
+912
| +1% | +USD 50.8 k | ﹤0.01% | 2608 |
|
|
2018
Q2 | USD 4.03 M | Compra |
85,566
+2,796
| +3% | +USD 154 k | ﹤0.01% | 2799 |
|
|
2018
Q1 | USD 4.68 M | Venta |
82,770
-2,004
| -2% | -USD 108 k | ﹤0.01% | 2628 |
|
|
2017
Q4 | USD 4.2 M | Venta |
84,774
-2,114
| -2% | -USD 131 k | ﹤0.01% | 2710 |
|
|
2017
Q3 | USD 6.61 M | Compra |
86,888
+12,182
| +16% | +USD 906 k | ﹤0.01% | 2454 |
|
|
2017
Q2 | USD 7.03 M | Compra |
74,706
+2,030
| +3% | +USD 174 k | ﹤0.01% | 2405 |
|
|
2017
Q1 | USD 5.77 M | Compra |
72,676
+3,820
| +6% | +USD 304 k | ﹤0.01% | 2467 |
|
|
2016
Q4 | USD 5.73 M | Compra |
68,856
+1,216
| +2% | +USD 110 k | ﹤0.01% | 2465 |
|
|
2016
Q3 | USD 7.56 M | Venta |
67,640
-255
| -0.4% | -USD 28.2 k | ﹤0.01% | 2250 |
|
|
2016
Q2 | USD 7.53 M | Venta |
67,895
-1,334
| -2% | -USD 162 k | ﹤0.01% | 2202 |
|
|
2016
Q1 | USD 7.24 M | Compra |
69,229
+640
| +0.9% | +USD 49.4 k | ﹤0.01% | 2185 |
|
|
2015
Q4 | USD 5.53 M | Compra |
68,589
+2,323
| +4% | +USD 185 k | ﹤0.01% | 2405 |
|
|
2015
Q3 | USD 4.6 M | Compra |
66,266
+1,000
| +2% | +USD 87.1 k | ﹤0.01% | 2487 |
|
|
2015
Q2 | USD 6.39 M | Compra |
65,266
+8,911
| +16% | +USD 952 k | ﹤0.01% | 2361 |
|
|
2015
Q1 | USD 5.52 M | Compra |
56,355
+1,763
| +3% | +USD 171 k | ﹤0.01% | 2444 |
|
|
2014
Q4 | USD 6.01 M | Venta |
54,592
-802
| -1% | -USD 98 k | ﹤0.01% | 2383 |
|
|
2014
Q3 | USD 6.55 M | Compra |
55,394
+41,227
| +291% | +USD 5.14 M | ﹤0.01% | 2333 |
|
|
2014
Q2 | USD 1.84 M | Compra |
14,167
+6,039
| +74% | +USD 713 k | ﹤0.01% | 3131 |
|
|
2014
Q1 | USD 1.3 M | Compra |
8,128
+634
| +8% | +USD 91 k | ﹤0.01% | 3320 |
|
|
2013
Q4 | USD 1.04 M | Compra |
7,494
+1,313
| +21% | +USD 131 k | ﹤0.01% | 3369 |
|
|
2013
Q3 | USD 615 k | Compra |
6,181
+1,998
| +48% | +USD 167 k | ﹤0.01% | 3422 |
|
|
2013
Q2 | USD 160 k | Compra |
+4,183
| Nuevas | +USD 127 k | ﹤0.01% | 3706 |
|
Otros fondos que tienen INO en su portafolio
Posición de Northern Trust en INO: resumen de T3 2026
Northern Trust aumentó su participación en Inovio Pharmaceuticals (INO) en 35% durante T3 2026, al comprar aproximadamente USD 67.9 k y elevar la posición a 235,260 acciones con un valor de USD 287 k. La posición representa ﹤0.01% del portafolio y ocupa el puesto #3800.
Northern Trust reportó por primera vez una posición en INO en T2 2013 y desde entonces la ha mantenido en 54 trimestres. La posición alcanzó su máximo de USD 50.7 M en T2 2020. Al cierre de T3 2026, 112 fondos que sigue Wall St. Rank mantienen una posición en INO.
- Al cierre de T3 2026, Northern Trust tenía 235,260 acciones de Inovio Pharmaceuticals con un valor de USD 287 k.
- Northern Trust compró 60,866 acciones de Inovio Pharmaceuticals en T3 2026, por un monto estimado de USD 67.9 k.
- Inovio Pharmaceuticals representó el ﹤0.01% del portafolio de Northern Trust en T3 2026 y fue su posición número 3800.
- Northern Trust reportó por primera vez una posición en Inovio Pharmaceuticals en T2 2013 y desde entonces la ha mantenido en 54 trimestres.
- La posición de Northern Trust en Inovio Pharmaceuticals alcanzó su máximo de USD 50.7 M en T2 2020.
- Al cierre de T3 2026, 112 fondos que sigue Wall St. Rank tenían Inovio Pharmaceuticals en su portafolio.
Según el informe 13F de Northern Trust correspondiente a T3 2026, presentado el 16 nov 2026.